Volume 29, Number 9—September 2023
Dispatch
Emergence of GII.4 Sydney[P16]-like Norovirus-Associated Gastroenteritis, China, 2020–2022
Table
Characteristic | GII.4 Sydney[P16] | GII.4 Sydney[P31] | p value† | GII.3[P12] | p value‡ |
---|---|---|---|---|---|
Total no. patients |
63 |
120 |
47 |
||
Median patient age, mo (IQR) |
21.5 (15–50.3) |
12 (9–19.3) |
<0.0001§ |
12 (8–26.75) |
0.004§ |
Age range, mo | |||||
<12 | 9 (14.3) | 47 (39.2) | 0.001¶ | 18 (38.3) | 0.004¶ |
12–36 | 31 (49.2) | 63 (52.5) | 0.672¶ | 19 (40.4) | 0.360¶ |
>36 |
23 (36.5) |
10 (8.3) |
<0.001¶ |
10 (21.3) |
0.085¶ |
F:M ratio |
0.58:1 |
0.5:1 |
0.744# |
0.48:1 |
0.688# |
Signs/symptoms | |||||
Total no. patients with signs/symptoms | 60 | 112 | NA | 44 | NA |
Diarrhea | 45 (75.0) | 93 (83.0) | 0.586¶ | 33 (75.0) | 0.579¶ |
Duration <5 d | 33 (73.3) | 64 (68.8) | 0.821¶ | 26 (78.8) | 0.837¶ |
Duration >5 d | 12 (26.7) | 29 (31.2) | 0.687¶ | 7 (21.2) | 0.664¶ |
Vomiting | 35 (58.3) | 40 (35.7) | <0.001¶ | 17 (38.6) | 0.047¶ |
Fever | 18 (30.0) | 20 (17.9) | 0.067¶ | 17 (38.6) | 0.357¶ |
Abdominal cramps | 9 (15) | 2 (1.8) | 0.02¶ | 6 (13.6) | 0.845¶ |
*Values are no. (%) patients except as indicated. Bold indicates statistical significance. NA, not applicable †Denotes comparison between GII.4 Sydney[P16] and GII.4 Sydney[P31]. ‡Indicates comparison between GII.4 Sydney[P16] and GII.3[P12]. §By χ2 test. ¶For the comparison of the median age between groups; calculated by Mann-Whitney U-test. #By Fisher exact test.
1These authors contributed equally to this article.
Page created: June 29, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.